Canada markets closed

ADMA Biologics, Inc. (ADMA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
6.46-0.08 (-1.22%)
At close: 04:00PM EDT
6.44 -0.02 (-0.31%)
After hours: 04:16PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
258,215
258,215
154,080
80,943
42,220
Cost of Revenue
169,273
169,273
118,815
79,770
61,291
Gross Profit
88,942
88,942
35,265
1,173
-19,072
Operating Expenses
Research Development
3,300
3,300
3,614
3,646
5,907
Selling General and Administrative
59,020
59,020
52,458
42,897
35,051
Total Operating Expenses
67,310
67,310
74,630
59,547
45,843
Operating Income or Loss
21,632
21,632
-39,365
-58,374
-64,915
Interest Expense
25,027
25,027
19,279
13,057
11,985
Total Other Income/Expenses Net
-26,461
-26,461
-7,305
-252
863.269
Income Before Tax
-28,239
-28,239
-65,904
-71,648
-75,749
Income from Continuing Operations
-28,239
-28,239
-65,904
-71,648
-75,749
Net Income
-28,239
-28,239
-65,904
-71,648
-75,749
Net Income available to common shareholders
-28,239
-28,239
-65,904
-71,648
-75,749
Basic EPS
-0.11
-
-0.33
-0.51
-0.88
Diluted EPS
-0.11
-
-0.33
-0.51
-0.88
Basic Average Shares
218,201
-
197,875
139,579
86,145
Diluted Average Shares
218,201
-
197,875
139,579
86,145